Stay updated on Taletrectinib ROS1+ NSCLC Clinical Trial

Sign up to get notified when there's something new on the Taletrectinib ROS1+ NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Taletrectinib ROS1+ NSCLC Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Revision: v3.5.5 has been added to the history, replacing the previous v3.5.4, representing an updated version of the page’s historical record.
    Difference
    0.1%
    Check dated 2026-06-05T11:14:34.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    Change Detected
    Summary
    The page history now includes a new revision entry labeled v3.5.4, updating the release notes metadata for this study record.
    Difference
    0.1%
    Check dated 2026-05-15T06:45:36.000Z thumbnail image
  5. Check
    47 days ago
    Change Detected
    Summary
    The site’s interface revision label updates from v3.5.2 to v3.5.3, reflecting a ClinicalTrials.gov platform/version release. No study-related information or record content changes are indicated by this change.
    Difference
    0.1%
    Check dated 2026-04-24T06:15:58.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    Added Revision: v3.5.2 to the history and removed Revision: v3.5.0.
    Difference
    0.1%
    Check dated 2026-04-17T02:51:05.000Z thumbnail image
  7. Check
    83 days ago
    Change Detected
    Summary
    Revision history now includes a new entry for v3.5.0 and removes the previous v3.4.3 entry.
    Difference
    0.1%
    Check dated 2026-03-19T04:12:44.000Z thumbnail image
  8. Check
    91 days ago
    Change Detected
    Summary
    A new revision entry v3.4.3 was added to the Record History, and the previous entry v3.4.2 was removed.
    Difference
    0.1%
    Check dated 2026-03-11T23:28:37.000Z thumbnail image

Stay in the know with updates to Taletrectinib ROS1+ NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Taletrectinib ROS1+ NSCLC Clinical Trial page.